Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin in Limb Reconstruction
NCT00624299Phase 4Withdrawn
- Sponsor
- Sheffield Children's Hospital
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in leg length discrepancy (LLD), Foot deformities, sponsored by Sheffield Children's Hospital. Planned start Mar 2008; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
leg length discrepancy (LLD)Foot deformities
Beyond the preview
Go deeper on NCT00624299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624299.